Frank Bartel

4.5k total citations · 1 hit paper
65 papers, 3.6k citations indexed

About

Frank Bartel is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frank Bartel has authored 65 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 34 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frank Bartel's work include Cancer-related Molecular Pathways (30 papers), Sarcoma Diagnosis and Treatment (15 papers) and Cancer Genomics and Diagnostics (10 papers). Frank Bartel is often cited by papers focused on Cancer-related Molecular Pathways (30 papers), Sarcoma Diagnosis and Treatment (15 papers) and Cancer Genomics and Diagnostics (10 papers). Frank Bartel collaborates with scholars based in Germany, United States and United Kingdom. Frank Bartel's co-authors include Helge Täubert, Matthias Bache, Peter Würl, Gareth L. Bond, Elisabeth E. Bond, Peter Wuerl, Arnold J. Levine, Harlan Robins, Linda C. Harris and Matthias Kappler and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frank Bartel

65 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

2004 1.0k citations Gareth L. Bond, Wenwei Hu et al. Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Frank Bartel	2.5k	1.9k	841	424	315	65	3.6k
Jane Weaver-Feldhaus	1.9k 0.7×	1.8k 1.0×	757 0.9×	316 0.7×	294 0.9×	10	3.1k
Patrizia Gasparini	2.3k 0.9×	1.4k 0.8×	576 0.7×	392 0.9×	288 0.9×	71	3.4k
Elizabeth E. Reczek	2.1k 0.8×	1.2k 0.6×	513 0.6×	304 0.7×	197 0.6×	10	3.2k
Byungwoo Ryu	1.7k 0.7×	1.3k 0.7×	568 0.7×	370 0.9×	216 0.7×	39	2.9k
Simone Spaderna	2.9k 1.1×	2.2k 1.2×	1.8k 2.1×	344 0.8×	323 1.0×	18	4.4k
Pascal H. G. Duijf	2.9k 1.1×	1.5k 0.8×	1.3k 1.6×	318 0.8×	530 1.7×	82	4.0k
Paul A. Berry	1.5k 0.6×	2.0k 1.1×	820 1.0×	686 1.6×	159 0.5×	24	3.0k
Dalong Qian	3.6k 1.4×	2.2k 1.1×	1.6k 1.9×	349 0.8×	534 1.7×	30	5.4k
Mariko Shimokawa	1.3k 0.5×	1.8k 1.0×	705 0.8×	159 0.4×	289 0.9×	16	2.8k
Nicholas A. Willis	3.7k 1.5×	2.3k 1.2×	998 1.2×	721 1.7×	501 1.6×	37	5.4k

Countries citing papers authored by Frank Bartel

Since Specialization

Citations

This map shows the geographic impact of Frank Bartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Bartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Bartel more than expected).

Fields of papers citing papers by Frank Bartel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Bartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Bartel. The network helps show where Frank Bartel may publish in the future.

Co-authorship network of co-authors of Frank Bartel

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Bartel. A scholar is included among the top collaborators of Frank Bartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Bartel. Frank Bartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Ping, Stefanie Hammer, Valeria Solozobova, et al.. (2015). TRIM25 has a dual function in the p53/Mdm2 circuit. Oncogene. 34(46). 5729–5738. 74 indexed citations

Boccuto, Luigi, Kazuhiro Aoki, Heather Flanagan‐Steet, et al.. (2013). A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Human Molecular Genetics. 23(2). 418–433. 131 indexed citations

Lenos, Kristiaan, Anna M. Grawenda, Kirsten Lodder, et al.. (2012). Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer. Cancer Research. 72(16). 4074–4084. 51 indexed citations

Bartel, Frank, Katharina Balschun, Elise Gradhand, et al.. (2012). Inverse Expression of Cystein-rich 61 (Cyr61/CCN1) and Connective Tissue Growth Factor (CTGF/CCN2) in Borderline Tumors and Carcinomas of the Ovary. International Journal of Gynecological Pathology. 31(5). 405–415. 7 indexed citations

Marom, Daphna, Charles E. Schwartz, Adi Har‐Zahav, et al.. (2011). X‐linked mental retardation with alacrima and achalasia—Triple A syndrome or a new syndrome?. American Journal of Medical Genetics Part A. 155(8). 1959–1963. 4 indexed citations

Böhnke, Anja, Eleonora Leucci, Søren Jensby Nielsen, et al.. (2010). An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity. Cancer Research. 70(23). 9641–9649. 141 indexed citations

Teunisse, Amina F.A.S., Suzanne Lam, Kirsten Lodder, et al.. (2010). HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity. Journal of Biological Chemistry. 285(38). 29111–29127. 44 indexed citations

Kappler, Matthias, Swetlana Rot, Helge Täubert, et al.. (2007). The effects of knockdown of wild-type survivin, survivin-2B or survivin-Δ3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Therapy. 14(12). 994–1001. 20 indexed citations

Bond, Gareth L., Wenwei Hu, Elisabeth E. Bond, et al.. (2004). A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans. Cell. 119(5). 591–602. 1026 indexed citations breakdown →

10.

Kappler, Matthias, Matthias Bache, Frank Bartel, et al.. (2004). Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Therapy. 11(3). 186–193. 99 indexed citations

11.

Seidel, Claudia, Frank Bartel, Matthias Rastetter, et al.. (2004). Alterations of cancer‐related genes in soft tissue sarcomas: Hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. International Journal of Cancer. 114(3). 442–447. 42 indexed citations

12.

Täubert, Helge, Frank Bartel, Matthias Kappler, et al.. (2003). Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer. 97(9). 2273–2278. 16 indexed citations

13.

Täubert, Helge, Katja Schuster, Ulrich Brinck, et al.. (2003). Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages. Modern Pathology. 16(11). 1109–1116. 8 indexed citations

14.

Bartel, Frank, Helge Täubert, & Linda C. Harris. (2002). Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell. 2(1). 9–15. 158 indexed citations

15.

Schmidt, H, Helge Täubert, Peter Würl, et al.. (2002). Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes and Cancer. 34(1). 69–77. 27 indexed citations

16.

Bache, Matthias, Axel Meye, Frank Bartel, et al.. (2001). Radiosensitization in sarcoma cell lines with a p53 missense mutation correlates with prevention of irradiation G2/M arrest but not with induction of apoptosis. Oncology Reports. 8(5). 1007–11. 3 indexed citations

17.

Kappler, Matthias, Marc Schmitz, Frank Bartel, et al.. (2001). Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients. International Journal of Cancer. 95(6). 360–363. 78 indexed citations

18.

Bartel, Frank, Tsukasa Higuchi, & Demetri D. Spyropoulos. (2000). Mouse models in the study of the Ets family of transcription factors. Oncogene. 19(55). 6443–6454. 90 indexed citations

19.

Täubert, Helge, Matthias Kappler, Axel Meye, et al.. (2000). A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 456(1-2). 39–44. 4 indexed citations

20.

Bittorf, Thomas, Hermann Walzel, Josef Brock, et al.. (2000). High Concentration of Soluble HLA-DR in the Synovial Fluid: Generation and Significance in “Rheumatoid-like” Inflammatory Joint Diseases. Cellular Immunology. 206(2). 85–100. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact